Drugs / Leucine-Enriched Essential Amino Acid powder
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06387186 | May 2024 → Feb 2026 | epilepsy | Elizabeth Anne Thiele | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Leucine-Enriched Essential Amino Acid powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06387186 ↗ |
| Known as | LEAA | “Leucine-Enriched Essential Amino Acid powder (LEAA) as an add-on to a classic ketogenic diet (KD)” NCT06387186 ↗ |
| Route | Oral | “orally/enterally administered” NCT06387186 ↗ |